Secular Trends in Long-term Sustained Hypertension, Long-term Treatment, and Cardiovascular Mortality

Author:

Sytkowski Pamela A.1,D’Agostino Ralph B.1,Belanger Albert J.1,Kannel William B.1

Affiliation:

1. From the Framingham Heart Study, Framingham, Mass (P.A.S., R.B.D., A.J.B., W.B.K.); the Statistics and Consulting Unit, Department of Mathematics, Boston (Mass) University (P.A.S., R.B.D., A.J.B.); and Section of Preventive Medicine, Department of Medicine, Boston University School of Medicine (W.B.K.).

Abstract

Background Cardiovascular morbidity and mortality result from the chronic processes involved in hypertension. However, long-term sustained (LTS) hypertension has received little attention. Methods and Results Trends in the prevalence of LTS hypertension and its treatment were assessed in 1950, 1960, and 1970 among three cohorts of men and women in the Framingham Heart Study (Mantel-Haenszel test). Cardiovascular disease (CVD) incidence and mortality were compared between patients with LTS hypertension with and without long-term treatment by use of the χ 2 test. Cox proportional hazards regression analysis was used to estimate 10-year risk of death as a function of risk factor levels and treatment. Prevalence of LTS hypertension rose from 138 to 208 per 1000 between the 1950 and 1970 male cohorts ( P <.01), while prevalence fell from 253 to 198 per 1000 between the female cohorts ( P <.02). Long-term treatment increased 51% between the male cohorts and 45% between the female cohorts (both P <.001). While CVD incidence was similar (26% versus 25%), all-cause mortality was significantly lower among men with long-term treatment (31% versus 43%; P <.05), and CVD mortality was less than half (13% versus 28%; P <.01). Among treated women, all-cause mortality was 21% (versus 34%; P <.01), and CVD mortality was 9% (versus 19%; P <.01). Ten-year risk of CVD death for patients with LTS hypertension with long-term treatment compared with those without was 0.40 (95% CI, 0.27 to 0.60). Conclusions This investigation of LTS hypertension, its treatment, and its sequelae in a free-living general population confirms the reduction in CVD mortality demonstrated in more short-term clinical trials of hypertension therapy in select patient groups.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference32 articles.

1. The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V)

2. Health United States 1990 . Hyattsville Md: Government Printing Office; 1991. DHHS publication 91-1232.

3. Morbidity and Mortality Chartbook on Cardiovascular Lung and Blood Disease − 1990 . Bethesda Md: Government Printing Office; 1990. National Heart Lung and Blood Institute.

4. Antihypertensive Therapy in Evolution

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3